New York State Common Retirement Fund Clene Inc. Transaction History

New York State Common Retirement Fund

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$2.1 - $4.12 $25,943 - $50,898	-12,354 Reduced 98.72%	160 $0
Q4 2021 Feb 02, 2022	SELL	$3.95 - $7.53 $181 - $346	-46 Reduced 0.37%	12,514 $51,000
Q3 2021 Nov 02, 2021	SELL	$6.83 - $13.58 $48,083 - $95,603	-7,040 Reduced 35.92%	12,560 $86,000
Q2 2021 Aug 02, 2021	BUY	$6.98 - $13.33 $136,808 - $261,268	19,600 New	19,600 $220,000

7.44M

48.1K

160K

Ticker CLNN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,502,000
Market Cap $21M
Description
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.